Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
eTherapeutics
company
About
eTherapeutics focuses on the discovery of cancer and degenerative diseases of the nervous system.
- 11 - 50
Highlights
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- £2M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2003
- Number Of Employee
- 11 - 50
- Operating Status
- Active
e-Therapeutics plc is a drug discovery and development company. It has developed proprietary computational systems to swiftly and accurately analyse and predict how medicines interact with cells in the body in hopes of optimizing the probability of identifying drug candidates with desirable efficacy and minimal side effects.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
£2M
eTherapeutics has raised a total of
£2M
in funding over 2 rounds. Their latest funding was raised on
Mar 18, 2009 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 18, 2009 | Post-IPO Equity | £2M | 1 |
Octopus Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
eTherapeutics is funded by 1 investors.
Octopus Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Octopus Ventures
|
Yes | Post-IPO Equity |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
